Mergers and acquisitions show no signs of slowing down in the biotech sector with a $3.5 billion acquisition agreement being announced. Meanwhile, Biogen (BIIB – Analyst Report) is advancing towards developing a treatment for Alzheimer’s disease.Recap of the Week’s Most Important Stories1. Biogen is set to move its experimental Alzheimer’s disease treatment, BIIB037, into late-stage testing based on promising interim […]
Benchmarks began December on a dismal note as discouraging domestic as well as overseas economic data dented investor sentiment on Monday. Moreover, decline in sales during Thanksgiving weekend also dragged down retail shares on Monday. However, rebound in oil prices boosted energy shares. The Nasdaq registered its biggest one-day decline in seven weeks and the S&P 500 witnessed the same […]
Benchmarks settled in the green on Wednesday due to gains in technology and telecom stocks. The S&P 500 and the Dow closed at a record level for the 47th and 30th times this year, respectively. Separately, the Nasdaq was boosted by gains in bio-tech stocks. However, the gains were limited by another slump in energy shares. Meanwhile, the day’s discouraging […]
Benchmarks finished almost unchanged on Tuesday as investors received mixed economic data while a slump in oil prices dragged energy shares down. While revised third-quarter GDP came in better-than-expected, data on consumer confidence and home prices were discouraging. The S&P 500 and the Dow snapped a three-session winning streak and ended in the red, but the Nasdaq settled in the […]
Markets retreated from record highs on Wednesday to finish in the red as Fed minutes failed to provide any clear indications about a possible rate hike. Moreover, mixed housing data also weighed on investor sentiment. However, upbeat earning results helped retail stocks to post solid gains on Wednesday.For a look at the issues currently facing the markets, make sure to […]
Benchmarks finished almost flat on Friday as Eurozone’s soft GDP data offset encouraging economic reports. Decline in healthcare stocks also eroded some of Friday’s gains. However, higher crude oil prices boosted energy shares. The meager gains helped the S&P 500 extend its record high. Moreover, benchmarks managed to register weekly gains for a fourth straight week.For a look at the […]
Benchmarks were little changed on Tuesday as investors hardly found any reason to place big bets. The day was devoid of any major news that could move the markets significantly on either side. Trading volumes were light and the bond market was closed due to the U.S. Veterans Day holiday. However, the S&P 500 and the Dow posted modest gains […]
Benchmarks were little changed on Friday after reports that the U.S. nonfarm payroll employment increased at a slower pace than expected, while unemployment rate declined to a six-year low. The S&P 500 and the Dow posted marginal gains, which were enough to help them settle at record highs for the third consecutive session. On the other hand, the Nasdaq failed […]
3 Biotech Stocks for Earnings Beats this SeasonEven a quarter back, tax inversion deals were quite a rage among most of the U.S. based biotech firms. However, these tax dodging strategies have fallen apart ever since the U.S. Department of Treasury issued a notice related to tax inversion deals. We have seen AbbVie Inc. ( ABBV ) calling off its […]
Benchmarks ended mostly in the negative territory on Wednesday after a drop in Apple shares weighed on the broader markets. A possibility of a cease-fire between Ukraine and Russia had initially lifted the markets. Meanwhile, investors were reluctant to bet big bucks ahead of the European Central Bank’s monthly policy meeting on Thursday.For a look at the issues currently facing […]
